Avalyn Pharma Inc. Common Stock (AVLN) vs Teladoc Health, Inc. (TDOC)

A side-by-side comparison of Avalyn Pharma Inc. Common Stock and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AVLN vs TDOC

growth of $100 · dividends reinvested · last 1y
AVLN -8.3% (-8.3%/yr)TDOC -4.5% (-4.5%/yr)TDOC compounded faster over this window
100120140160Start $100$92$96
AVLN TDOC

AVLN vs TDOC: by the numbers

  • •AVLN is the larger company ($1.17B vs $1.04B market cap).
  • •Both run net losses; AVLN's is the smaller (0.00% vs -7.13% net margin).

Metrics side by side

Valuation

MetricAVLNTDOC
P/S ratioN/A0.42
P/B ratio2.930.79
EV / EBITDAN/A12.82
FCF yieldN/A21.58%

Profitability

MetricAVLNTDOC
Gross margin0.00%73.53%
Operating margin0.00%-6.98%
Net margin0.00%-7.13%
ROEN/A-13.54%
ROIC-67.73%-7.32%

Growth (annualized)

MetricAVLNTDOC
Revenue CAGR (5Y)N/A8.85%
Total return CAGR (5Y)N/A-45.85%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.